Compare · BMGL vs CHE
BMGL vs CHE
Side-by-side comparison of Basel Medical Group Ltd (BMGL) and Chemed Corp (CHE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BMGL and CHE operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE carries a market cap of $7.14B.
- Over the past year, BMGL is down 85.7% and CHE is down 25.4% - CHE leads by 60.3 points.
- Both names hit the wire about 6 times in the past 4 weeks.
- CHE has more recent analyst coverage (6 ratings vs 0 for BMGL).
- Company
- Basel Medical Group Ltd
- Chemed Corp
- Price
- $0.60-3.08%
- $421.57+9.84%
- Market cap
- -
- $7.14B
- 1M return
- -10.31%
- +12.75%
- 1Y return
- -85.73%
- -25.40%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 6
- 6
- Recent ratings
- 0
- 6
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Latest BMGL
- SEC Form 3 filed by new insider Soong Kwek Yoon
- SEC Form 3 filed by new insider Lu Jianing Jn
- SEC Form 3 filed by new insider Chen Tony
- SEC Form 3 filed by new insider Chhoa Darren Yen Feng
- SEC Form 3 filed by new insider Tan Boon Chye
- SEC Form 3 filed by new insider Fung Keng Leong
- SEC Form 6-K filed by Basel Medical Group Ltd
- SEC Form 6-K filed by Basel Medical Group Ltd
- Compliance With Nasdaq Periodic Filing Requirement
- Amendment: SEC Form 20-F/A filed by Basel Medical Group Ltd
Latest CHE
- Chemed Corp filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Chemed Reports First-Quarter 2026 Results
- Chemed Corp filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement
- SEC Form DEFR14A filed by Chemed Corp
- SEC Form DEF 14A filed by Chemed Corp
- Chemed To Report First Quarter 2026 Earnings April 23, Related Conference Call To Be Held On April 24
- Roto-Rooter Completes Acquisitions for Two Significant Territories
- SEC Form 4 filed by Mcnamara Kevin J
- Now Open: VITAS® Healthcare Inpatient Hospice Care at Oak Manor